Market Research Reports- Consulting Analysis Crystal Market Research Diabetic Retinopathy Market by Type and Management

Diabetic Retinopathy Market is Projected To
be Around $2.6 Billion By 2025
A research study titled, “Diabetic Retinopathy Market by Type, Treatment, and End User - Global
Industry Analysis and Forecast to 2025” published by Crystal Market Research, states that the
diabetic retinopathy market is projected to be around $2.6 billion by 2025.
Diabetic retinopathy (DR) is a condition that occurs in individuals suffering from diabetes. It is a severe
sight-threatening problem of diabetes which progressively damages the light-sensitive lining at the back
of the eye i.e. retina. This condition occurs when blood vessels leak blood. Therefore, the retinal tissue
swells leading to blurred vision. If DR is not treated on time, it can cause blindness. According to a study
conducted by American Diabetes Association, 415 million people worldwide suffered from diabetes and
diabetes related complications as of 2015, and this number is expected to reach 642 million by 2040.
Prevalence of diabetes retinopathy is higher in people suffering from type-1 diabetes for prolonged
period. Such high incidence of diabetic retinopathy can be attributed to rise in chronic conditions such as
hyperglycemia, rise in obesity rate, rise in hypertension, and genetic factors of individuals.
Browse full research report with TOC on “Diabetic Retinopathy Market by Type, Treatment, and
End User - Global Industry Analysis and Forecast to 2025” at:
http://www.crystalmarketresearch.com/report/diabetic-retinopathy-market
Diabetic macular edema market is expected to witness high growth during forecast period. This can be
attributed to number of factors such as rise in prevalence of diabetic retinopathy, growing aging
population and the changing lifestyle. Anti-VEGF treatment segment accounted for the largest share due
to more usage of these medicines for quicker recovery of patients. However, laser surgery segment is
expected to witness high growth rate during the forecast period.
North America dominated the global diabetic retinopathy market in 2016. This can be attributed to
number of factors such as increasing prevalence of diabetes, high adoption of advanced products, and
favorable reimbursement policies. Asia-Pacific is expected to witness high growth rate, due to high